Use of combination of low-dose cyclosporine and RS-61443 in a rat hindlimb model of composite tissue allotransplantation

Transplantation

Volumn 61, Issue 4, 1996, Pages 527-532

  Benhaim, Prosper ^a   Anthony, James P ^a   Ferreira, Lydia ^a   Borsanyi, Jean Pierre ^a   Mathes, Stephen J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ALLOTRANSPLANTATION; ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TOXICITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; DRUG SCREENING; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; GRAFT REJECTION; HEMATOCRIT; HINDLIMB; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; RATS; RATS, INBRED BN; RATS, INBRED F344; TRANSPLANTATION IMMUNOLOGY;

EID: 0029863134     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199602270-00002     Document Type: Article

References (49)

1. Benhaim P, Anthony JP. Reconstructive allotransplantation: current research and future clinical applications. Perspect Plast Surg 1992; 6: 47.
2. Murray JE. Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast Reconstr Surg 1971; 47: 425.
3. Sakai A, Yakushiji K, Mashimo S. Lymphocyte stimulation by allogeneic tissue cells in rats: with special reference to differential survival of skin and kidney allografts. Transplant Proc 1980; 12: 74.
4. Skanes SE, Samulack DD, Daniel RK. Tissue transplantation for reconstructive surgery. Transplant Proc 1986; 18: 898.
5. Birinyi LK, Baldwin WM, Tilney NL. Differential effects of heterologous antisera on the survival of cardiac and skin allografts in rats. Transplantation 1981; 32: 336.
6. Hotokebuchi T, Arai K, Takagishi K, Arita C, Sugioka Y, Kaibara N. Limb allografts in rats immunosuppressed with cyclosporine: as a whole-joint allograft. Plast Reconstr Surg 1989; 83: 1027.
7. Kuroki H, Ikuta Y, Akiyama M. Experimental studies of vascularized allogeneic limb transplantation in the rat using a new immunosuppressive agent, FK-506: morphological and immunological analysis. Transplant Proc 1989; 21: 3187.
8. Hovius SER, Stevens HPJD, van Nierop PWM, Rating W, van Strik R, van der Meulen JC. Allogeneic transplantation of the radial side of the hand in the rhesus monkey: I. technical aspects. Plast Reconstr Surg 1992; 89: 700.
9. Gold ME, Randzio J, Kniha H, et al. Transplantation of vascularized composite mandibular allografts in young cynomolgus monkeys. Ann Plast Surg 1991; 26: 125.
10. Hewitt CW, Black KS, Achauer BM, Mayuri PP. Reconstructive allotransplantation: considerations regarding integumentary/musculoskeletal grafts, cyclosporine, wound coverage in thermal injury, and the immune response. J Burn Care Rehabil 1990; 11: 74.
11. Doi K. Homotransplantation of limbs in rats: preliminary report on an experimental study with nonspecific immunosuppressive drugs. Plast Reconstr Surg 1979; 64: 613.
12. Black KS, Hewitt CW, Woodard TL, et al. Efforts to enhance survival of limb allografts by prior administration of whole blood in rats using a new survival end-point. J Microsurg 1982; 3: 162.
13. Van Buren CT. Cyclosporine: progress, problems, and perspectives. Surg Clin N America 1986; 66: 435.
14. Black KS, Hewitt CW, Fraser LA, et al. Cosmas and Damian in the laboratory. N Engl J Med 1982; 306: 368.
15. Hewitt CW, Black KS, Fraser LA, et al. Cyclosporin-A (CyA) is superior to prior donor-specific blood (DSB) transfusion for the extensive prolongation of rat limb allograft survival. Transplant Proc 1983; 15: 514.
16. Furnas DW, Black KS, Hewitt CW, Fraser LA, Achauer BM. Cyclosporine and long-term survival of composite tissue allografts (limb transplants) in rats with historical notes on the role of plastic surgeons in allotransplantation. Transplant Proc 1983; 15: 3063.
17. Black KS, Hewitt CW, Fraser LA, et al. Composite tissue (limb) allografts in rats: II. Indefinite survival using low-dose cyclosporine. Transplantation 1985; 39: 365.
18. Benhaim P, Anthony JP, Lin LY, McCalmont TH, Mathes SJ. A long-term study of allogeneic rat hindlimb transplants immunosuppressed with RS-61443. Transplantation 1993; 56: 911.
19. Fritz WD, Swartz WM, Rose S, Futrell JW, Klein E. Limb allografts in rats immunosuppressed with cyclosporin A. Ann Surg 1984; 199; 211.
20. Morris RE, Hoyt EG, Murphy MP, Eugui EM, Allison AC. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis. Transplant Proc 1990; 22: 1659.
21. Hao L, Lafferty KJ, Allison AC, Eugui EM. RS-61443 allows islet allografting and specific tolerance induction in adult mice. Transplant Proc 1990; 22: 876.
22. Ensley RD, Bristow MR, Olsen SL, et al. The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients. Transplantation 1993; 56: 75.
23. Kirklin JK, Bourge RC, Naftel DC, et al. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience. J Heart Lung Transplant 1994; 13: 444.
24. Sollinger HW, Belzer FO, Deierhoi MH, et al. RS-61443 (mycophenolate mofetil): a multicenter study for refractory kidney transplant rejection. Ann Surg 1992; 216: 513.
25. Lee WA, Gu L, Miksztal AR, Chu N, Leung K, Nelson PH. unavailability improvement of mycophenolic acid through amino ester derivatization. Pharm Res 1990; 7: 161.
26. Goldblum R. Therapy of rheumatoid arthritis with mycophenolate mofetil. Clin Exp Rheumatol 1993; S117.
27. Knechtle SJ, Wang J, Burlingham WJ, Beeskau M, Subramanian R, Sollinger HW. The influence of RS-61443 on antibody-mediated rejection. Transplantation 1992; 53: 699.
28. Platz KP, Eckhoff DE, Hullett DA, Sollinger HW. Prolongation of dog renal allograft survival by RS-61443, a new, potent immunosuppressive agent. Transplant Proc 1991; 23: 497.
29. Platz KP, Sollinger HW, Hullett DA, Eckhoff DE, Eugui EM, Allison AC. RS-61443 - a new, potent immunosuppressive agent. Transplantation 1991; 51: 27.
30. Morris RE, Wang J, Blum JR, et al. Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts. Transplant Proc 1991; 23: 19.
31. Morris RE, Wang J. Comparison of the immunosuppressive effects of mycophenolic acid and the morpholinoethyl ester of mycophenolic acid (RS-61443) in recipients of heart allografts. Transplant Proc 1991; 23: 493.
32. Wang J, Morris RE. Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival. Transplant Proc 1991; 23: 699.
33. Hao L, Calcinaro F, Gill RG, Eugui EM, Allison AC, Lafferty KJ. Facilitation of specific tolerance induction in adult mice by RS-61443. Transplantation 1992; 53: 590.
34. Nelson PH, Eugui E, Wang CC, Allison AC. Synthesis and immunosuppressive activity of some side-chain variants of mycophenolic acid. J Med Chem 1990; 33: 833.
35. Cohen MB, Sadee W. Contributions of the depletions of guanine and adenine nucleotides to the toxicity of purine starvation in the mouse T lymphoma cell line. Cancer Res 1983; 43: 1587.
36. Eugui EM, Mirkovich A, Allison AC. Lymphocyte-selective anti-proliferative and immunosuppressive effects of mycophenolic acid in mice. Scand J Immunol 1991; 33: 175.
37. Allison AC, Almquist SJ, Muller CD, Eugui EM. In vitro immunosuppressive effects of mycophenolic acid and an ester prodrug, RS-61443. Transplant Proc 1991; 23: 10.
38. van den Helder TBM, Benhaim P, Anthony JP, McCalmont TH, Mathes SJ. Efficacy of RS-61443 in reversing acute rejection in a rat model of hindlimb allotransplantation. Transplantation 1993; 57: 427.
39. Hewitt CW, Black KS, Fraser LA, et al. Composite tissue (limb) allografts in rats. I. Dose-dependent increase in survival with cyclosporine. Transplantation 1985; 39: 360.
40. Komatsu S, Tamai S. Successful replantation of a completely cut-off thumb. Case report. Plast Reconstr Surg 1968; 42: 374.
41. Buncke HJ, Buncke CM, Schulz WP. Immediate Nicoladoni procedure in the rhesus monkey, or hallux-to-hand transplantation, utilising microminiature vascular anastomoses. Br J Plast Surg 1966; 19: 332.
42. Buncke HJ, Schulz WR. Experimental digital amputation and reimplantation. Plast Reconstr Surg 1965; 36: 62.
43. Harii K, Ohmori K, Ohmori S. Successful clinical transfer often free flaps by microvascular anastomoses. Plast Reconstr Surg 1974; 53: 259.
44. D'Alessandro AM, Rankin M, McVey J, et al. Prolongation of canine intestinal allograft survival with RS-61443, cyclosporine, and prednisone. Transplantation 1993; 55: 695.
45. Bechstein WO, Schilling M, Steele DM, Hullett DA, Sollinger HW. RS-61443/cyclosporine combination therapy prolongs canine liver allograft survival. Transplant Proc 1993; 702.
46. Eugui EM, Mirkovich A, Allison AC. Lymphocyte-selective anti-proliferative and immunosuppressive activity of mycophenolic acid and its morpholinoethyl ester (RS-61443) in rodents. Transplant Proc 1991; 23: 15.
47. Sollinger HW, Deierhoi MH, Belzer FO, Diethelm AG, Kauffman RS. RS-61443 - a phase I clinical trial and pilot rescue study. Transplantation 1992; 53: 428.
48. Taylor DO, Ensley RD, Olsen SL, Dunn D, Renlund DG. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation. J Heart Lung Transplant 1994; 13: 571.
49. Steinmuller DR. Cyclosporine nephrotoxicity. Cleve Clin J Med 1989; 56: 89.